iifl-logo

Sandu Pharmaceuticals Ltd Share Price

50.5
(1.08%)
Jun 20, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open50.95
  • Day's High50.95
  • 52 Wk High69.5
  • Prev. Close49.96
  • Day's Low50
  • 52 Wk Low 43.75
  • Turnover (lac)0.27
  • P/E31.56
  • Face Value10
  • Book Value43.49
  • EPS1.6
  • Mkt. Cap (Cr.)48.79
  • Div. Yield0
View All Historical Data
No Records Found

Sandu Pharmaceuticals Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

50.95

Prev. Close

49.96

Turnover(Lac.)

0.27

Day's High

50.95

Day's Low

50

52 Week's High

69.5

52 Week's Low

43.75

Book Value

43.49

Face Value

10

Mkt Cap (₹ Cr.)

48.79

P/E

31.56

EPS

1.6

Divi. Yield

0

Sandu Pharmaceuticals Ltd Corporate Action

12 Aug 2024

12:00 AM

AGM

Announcement Date: 12 Aug, 2024

arrow

12 Aug 2024

12:00 AM

Dividend

Dividend Amount: 0.8

arrow

17 May 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Sandu Pharmaceuticals Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Sandu Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT

21 Jun, 2025|05:22 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 42.90%

Foreign: 0.00%

Indian: 42.90%

Non-Promoter- 0.01%

Institutions: 0.00%

Non-Institutions: 57.09%

Custodian: 0.00%

Share Price

Sandu Pharmaceuticals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

9.66

9.66

9.25

8.82

Preference Capital

0

0

0

0

Reserves

30.93

29.58

27.22

24.67

Net Worth

40.59

39.24

36.47

33.49

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

58.75

48.36

49.01

42.82

yoy growth (%)

21.47

-1.32

14.45

4.25

Raw materials

-34.5

-25.11

-28.39

-25.63

As % of sales

58.71

51.92

57.92

59.86

Employee costs

-8.01

-6.85

-5.93

-5.41

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

1.68

0.92

0.75

-0.03

Depreciation

-0.55

-0.55

-0.6

-0.86

Tax paid

-0.58

-0.19

-0.19

-0.49

Working capital

5.71

-2.3

-5.65

-2.17

Other operating items

View Cash Flow
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

21.47

-1.32

14.45

4.25

Op profit growth

48.33

-40.99

33.22

-36.08

EBIT growth

32.42

-31.72

36.55

-38.08

Net profit growth

51.66

28.27

-226.4

-182.58

View Ratios
Particulars (Rupees in Crores.)Mar-2025Mar-2024Mar-2023Mar-2022

Gross Sales

67.19

67.28

65.35

65.5

Excise Duty

0

0

0

0

Net Sales

67.19

67.28

65.35

65.5

Other Operating Income

0

0

0

0

Other Income

0.17

0.42

0.33

0.08

Sandu Pharmaceuticals Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,647.35

92.293,95,254.452,000.460.977,107.14101.44

Divis Laboratories Ltd

DIVISLAB

6,493.2

78.031,72,374.066670.462,536561.08

Cipla Ltd

CIPLA

1,483.15

24.331,19,795.191,485.41.084,254.47397.41

Dr Reddys Laboratories Ltd

DRREDDY

1,326.4

20.691,10,689.831,200.70.65,546.3345.79

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,167.95

56.271,07,213.014741.012,385224.33

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Sandu Pharmaceuticals Ltd

Management

Register Office

Registrar Office

Non-Exec & Non-Independent Dir

Shashank B Sandu

Managing Director

Umesh B Sandu

Company Sec. & Compli. Officer

Pratika Mhambray

Independent Director

Vijay Kottapalli

Non Executive Director

Jayshree Sandu

Chairman & Independent Directo

Balaram Vishwanathan

Independent Director

Ajit Rajaram Kantak

Registered Office

Plot No 25/26/29 & 30,

Pilerne Indl Estate Marra Bard,

Goa - 403511

Tel: -

Website: http://www.sandu.in

Email: corp.sec@sandu.in

Registrar Office

C-101 247 Park,

L B S Marg, Vikhroli West,

Mumbai - 400083

Tel: 91-22-28515644/5606

Website: www.sharexindia.com

Email: support@sharexindia.com

Summary

Sandu Pharmaceuticals Ltd (SPL) was established in 1985. The Company is mainly engaged in the business of manufacturing and trading of Ayurvedic medicines under the brand name SANDU.SPL came out with ...
Read More

Company FAQs

What is the Sandu Pharmaceuticals Ltd share price today?

The Sandu Pharmaceuticals Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹50.5 today.

What is the Market Cap of Sandu Pharmaceuticals Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Sandu Pharmaceuticals Ltd is ₹48.79 Cr. as of 20 Jun ‘25

What is the PE and PB ratio of Sandu Pharmaceuticals Ltd?

The PE and PB ratios of Sandu Pharmaceuticals Ltd is 31.56 and 1.16 as of 20 Jun ‘25

What is the 52 Week High and Low of Sandu Pharmaceuticals Ltd?

The 52-week high/low is the highest and lowest price at which a Sandu Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Sandu Pharmaceuticals Ltd is ₹43.75 and ₹69.5 as of 20 Jun ‘25

What is the CAGR of Sandu Pharmaceuticals Ltd?

Sandu Pharmaceuticals Ltd's CAGR for 5 Years at 23.41%, 3 Years at -6.59%, 1 Year at -15.51%, 6 Month at -11.39%, 3 Month at -3.90% and 1 Month at -9.51%.

What is the shareholding pattern of Sandu Pharmaceuticals Ltd?

The shareholding pattern of Sandu Pharmaceuticals Ltd is as follows:
Promoters - 42.90 %
Institutions - 0.01 %
Public - 57.09 %
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.